Expertise in
2
conditions

Benedetta T. Piccoli-Beretta

Lugano, TI, CH 
Clinical Trials:Currently Recruiting for 2 Trials
Expertise in
2
conditions
Lugano, TI, CH 
OverviewLocationsClinical Research

Overview

Benedetta Piccoli-Beretta practices in Lugano, Switzerland. Ms. Piccoli-Beretta is highly rated in 2 conditions, according to our data. Her top areas of expertise are Autoimmune Hepatitis, Primary Biliary Cholangitis, Cholangitis, Cholestasis, and Liver Transplant.

Her clinical research consists of co-authoring 11 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Lugano, TI, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Swiss Autoimmune Hepatitis Cohort Study
Swiss Autoimmune Hepatitis Cohort Study
Enrollment Status: Recruiting
Publish Date: August 18, 2025
Swiss Primary Biliary Cholangitis Cohort Study
Swiss Primary Biliary Cholangitis Cohort Study
Enrollment Status: Recruiting
Publish Date: August 17, 2025
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
View 1 Less Clinical Trial

11 Total Publications

Hepatic encephalopathy and MELD-Na predict treatment benefit in autoimmune hepatitis-related decompensated cirrhosis.
Hepatic encephalopathy and MELD-Na predict treatment benefit in autoimmune hepatitis-related decompensated cirrhosis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: August 17, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Piccoli-Beretta's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile